• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MicroRNA-130a 通过靶向 SOX4 调节直肠癌的放射敏感性。

MicroRNA-130a modulates a radiosensitivity of rectal cancer by targeting SOX4.

机构信息

Laboratory of Cancer Cell Biology, Department of Biochemistry, Gachon University School of Medicine, Incheon 21999, Republic of Korea.

Department of Health Sciences and Technology, GAIHST, Gachon University, Incheon 21999, Republic of Korea.

出版信息

Neoplasia. 2019 Sep;21(9):882-892. doi: 10.1016/j.neo.2019.07.005. Epub 2019 Aug 3.

DOI:10.1016/j.neo.2019.07.005
PMID:31387015
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6690642/
Abstract

Radioresistance poses a major challenge in the treatment of advanced rectal cancer. Therefore, understanding the detailed mechanisms of radioresistance may improve patient response to irradiation and the survival rate. To identify the novel targets that modulate the radiosensitivity of rectal cancer, we performed small RNA sequencing with human rectal cancer cell lines. Through bioinformatics analysis, we selected microRNA-310a (miR-130a) as a promising candidate to elucidate radioresistance. miR-130a was dramatically upregulated in radiosensitive rectal cancer cells and overexpression of miR-130a promotes rectal cancer cell radiosensitivity. Mechanically, miR-130a reversed the epithelial-mesenchymal transition phenotype of rectal cancer cells following inhibition of cell invasion upon irradiation. Moreover, miR-130a also inhibited the repair of irradiation-induced DNA damage followed by cell death. We identified that SOX4 was a direct target of miR-130a. Overexpression of SOX4 reversed the promotion activity of miR-130a on radiosensitivity. Together, our findings suggest that miR-130a functions as a radiosensitizer in rectal cancer and reveals a potential therapeutic target and preoperative prognostic marker for radiotherapy.

摘要

放射抵抗性是治疗晚期直肠癌的主要挑战。因此,了解放射抵抗性的详细机制可能会提高患者对放疗的反应和生存率。为了确定调节直肠癌放射敏感性的新靶标,我们用人直肠癌细胞系进行了小 RNA 测序。通过生物信息学分析,我们选择 microRNA-310a (miR-130a) 作为一个有前途的候选物来阐明放射抵抗性。miR-130a 在放射敏感的直肠癌细胞中显著上调,过表达 miR-130a 可促进直肠癌细胞的放射敏感性。机制上,miR-130a 抑制细胞侵袭后,逆转了照射诱导的直肠癌细胞上皮-间充质转化表型。此外,miR-130a 还抑制了照射诱导的 DNA 损伤的修复,从而导致细胞死亡。我们鉴定出 SOX4 是 miR-130a 的直接靶标。SOX4 的过表达逆转了 miR-130a 对放射敏感性的促进作用。总之,我们的研究结果表明,miR-130a 作为直肠癌的放射增敏剂发挥作用,并揭示了放射治疗的潜在治疗靶点和术前预后标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/6690642/de720ef82b7f/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/6690642/a50b88d005c5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/6690642/60edf6b76940/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/6690642/0a99b9dc1c82/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/6690642/4b021f34312d/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/6690642/fc100b338fee/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/6690642/a973782b2926/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/6690642/de720ef82b7f/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/6690642/a50b88d005c5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/6690642/60edf6b76940/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/6690642/0a99b9dc1c82/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/6690642/4b021f34312d/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/6690642/fc100b338fee/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/6690642/a973782b2926/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a291/6690642/de720ef82b7f/gr7.jpg

相似文献

1
MicroRNA-130a modulates a radiosensitivity of rectal cancer by targeting SOX4.MicroRNA-130a 通过靶向 SOX4 调节直肠癌的放射敏感性。
Neoplasia. 2019 Sep;21(9):882-892. doi: 10.1016/j.neo.2019.07.005. Epub 2019 Aug 3.
2
MicroRNA-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1.微小RNA-320通过靶向SOX4、FOXM1和FOXQ1抑制结直肠癌。
Oncotarget. 2016 Jun 14;7(24):35789-35802. doi: 10.18632/oncotarget.8937.
3
MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.MicroRNA-132/212上调通过靶向SOX4抑制转化生长因子-β介导的前列腺癌细胞上皮-间质转化
Prostate. 2016 Dec;76(16):1560-1570. doi: 10.1002/pros.23241. Epub 2016 Aug 16.
4
MicroRNA-25 suppresses proliferation, migration, and invasion of osteosarcoma by targeting SOX4.微小RNA-25通过靶向SOX4抑制骨肉瘤的增殖、迁移和侵袭。
Tumour Biol. 2017 Jul;39(7):1010428317703841. doi: 10.1177/1010428317703841.
5
Hsa-miR-24-3p increases nasopharyngeal carcinoma radiosensitivity by targeting both the 3'UTR and 5'UTR of Jab1/CSN5.人源微小RNA-24-3p通过靶向Jab1/CSN5的3'非翻译区和5'非翻译区增加鼻咽癌放射敏感性。
Oncogene. 2016 Nov 24;35(47):6096-6108. doi: 10.1038/onc.2016.147. Epub 2016 May 9.
6
SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells.SOX4与EZH2和HDAC3相互作用,以抑制侵袭性食管癌细胞中的微小RNA-31。
Mol Cancer. 2015 Feb 3;14:24. doi: 10.1186/s12943-014-0284-y.
7
H19 Functions as a Competing Endogenous RNA to Regulate EMT by Sponging miR-130a-3p in Glioma.H19作为一种竞争性内源性RNA,通过在胶质瘤中吸附miR-130a-3p来调节上皮-间质转化。
Cell Physiol Biochem. 2018;50(1):233-245. doi: 10.1159/000494002. Epub 2018 Oct 3.
8
MicroRNA-130a promotes the metastasis and epithelial-mesenchymal transition of osteosarcoma by targeting PTEN.微小RNA-130a通过靶向磷酸酶和张力蛋白同源物(PTEN)促进骨肉瘤的转移和上皮-间质转化。
Oncol Rep. 2016 Jun;35(6):3285-92. doi: 10.3892/or.2016.4719. Epub 2016 Mar 31.
9
The SOX4/miR-17-92/RB1 Axis Promotes Prostate Cancer Progression.SOX4/miR-17-92/RB1 轴促进前列腺癌进展。
Neoplasia. 2019 Aug;21(8):765-776. doi: 10.1016/j.neo.2019.05.007. Epub 2019 Jun 22.
10
MicroRNA-212 functions as a tumor-suppressor in human non-small cell lung cancer by targeting SOX4.MicroRNA-212 通过靶向 SOX4 在人类非小细胞肺癌中发挥肿瘤抑制作用。
Oncol Rep. 2017 Oct;38(4):2243-2250. doi: 10.3892/or.2017.5885. Epub 2017 Aug 7.

引用本文的文献

1
Radioresistance in rectal cancer: can nanoparticles turn the tide?直肠癌中的放射抗性:纳米颗粒能否扭转局面?
Mol Cancer. 2025 Jan 30;24(1):35. doi: 10.1186/s12943-025-02232-x.
2
Understanding the molecular mechanism responsible for developing therapeutic radiation-induced radioresistance of rectal cancer and improving the clinical outcomes of radiotherapy - A review.了解导致直肠癌治疗性辐射诱导放射抵抗的分子机制,并改善放射治疗的临床结果 - 综述。
Cancer Biol Ther. 2024 Dec 31;25(1):2317999. doi: 10.1080/15384047.2024.2317999. Epub 2024 Mar 6.
3
Improving the prediction for the response to radiotherapy of clinical tumor samples by using combinatorial model of MicroRNA expression.

本文引用的文献

1
microRNA-23a in Human Cancer: Its Roles, Mechanisms and Therapeutic Relevance.人类癌症中的微小RNA-23a:其作用、机制及治疗意义
Cancers (Basel). 2018 Dec 20;11(1):7. doi: 10.3390/cancers11010007.
2
microRNA-16-5p enhances radiosensitivity through modulating Cyclin D1/E1-pRb-E2F1 pathway in prostate cancer cells.微小 RNA-16-5p 通过调节前列腺癌细胞中的细胞周期蛋白 D1/E1-pRb-E2F1 通路增强放射敏感性。
J Cell Physiol. 2019 Aug;234(8):13182-13190. doi: 10.1002/jcp.27989. Epub 2018 Dec 10.
3
Preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer: Meta-analysis with trial sequential analysis of long-term survival data.
利用微小RNA表达组合模型改善临床肿瘤样本放疗反应预测
Front Genet. 2022 Nov 22;13:1069112. doi: 10.3389/fgene.2022.1069112. eCollection 2022.
4
lncRNA PCGEM1 Regulates the Progress of Colorectal Cancer through Targeting miR-129-5p/SOX4.长链非编码 RNA PCGEM1 通过靶向 miR-129-5p/SOX4 调控结直肠癌的进展。
Dis Markers. 2022 Sep 20;2022:2876170. doi: 10.1155/2022/2876170. eCollection 2022.
5
Epithelial-Mesenchymal Transition-Mediated Tumor Therapeutic Resistance.上皮-间质转化介导的肿瘤治疗抵抗
Molecules. 2022 Jul 25;27(15):4750. doi: 10.3390/molecules27154750.
6
Biomarkers of Favorable vs. Unfavorable Responses in Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy.局部晚期直肠癌患者接受新辅助同期放化疗的有利和不利反应的生物标志物。
Cells. 2022 May 11;11(10):1611. doi: 10.3390/cells11101611.
7
The Roles of Non-Coding RNAs in Radiotherapy of Gastrointestinal Carcinoma.非编码RNA在胃肠道癌放射治疗中的作用
Front Cell Dev Biol. 2022 Apr 20;10:862563. doi: 10.3389/fcell.2022.862563. eCollection 2022.
8
Inhibition of the lncRNA prevents podocyte injury and mitotic catastrophe in diabetic nephropathy.抑制长链非编码RNA可预防糖尿病肾病中的足细胞损伤和有丝分裂灾难。
Mol Ther Nucleic Acids. 2022 Mar 8;28:136-153. doi: 10.1016/j.omtn.2022.03.001. eCollection 2022 Jun 14.
9
MiR-596 down regulates SOX4 expression and is a potential novel biomarker for gastric cancer.微小RNA-596下调SOX4表达,是胃癌潜在的新型生物标志物。
Transl Cancer Res. 2020 Feb;9(2):1294-1302. doi: 10.21037/tcr.2020.02.02.
10
Circular RNA circ_0000518 promotes breast cancer progression through the microRNA-1225-3p/SRY-box transcription factor 4 pathway.环状 RNA circ_0000518 通过 microRNA-1225-3p/SRY-box 转录因子 4 通路促进乳腺癌进展。
Bioengineered. 2022 Feb;13(2):2611-2622. doi: 10.1080/21655979.2021.2019877.
术前短程放疗和长程放化疗治疗局部进展期直肠癌:长期生存数据的荟萃分析与试验序贯分析。
PLoS One. 2018 Jul 12;13(7):e0200142. doi: 10.1371/journal.pone.0200142. eCollection 2018.
4
Targeting MicroRNAs in Prostate Cancer Radiotherapy.靶向前列腺癌放射治疗中的 microRNAs。
Theranostics. 2017 Jul 23;7(13):3243-3259. doi: 10.7150/thno.19934. eCollection 2017.
5
Downregulation of miR-130a promotes cell growth and epithelial to mesenchymal transition by activating HMGB2 in glioma.miR-130a的下调通过激活胶质瘤中的HMGB2促进细胞生长和上皮-间质转化。
Int J Biochem Cell Biol. 2017 Dec;93:25-31. doi: 10.1016/j.biocel.2017.08.010. Epub 2017 Aug 26.
6
MicroRNA-25 suppresses proliferation, migration, and invasion of osteosarcoma by targeting SOX4.微小RNA-25通过靶向SOX4抑制骨肉瘤的增殖、迁移和侵袭。
Tumour Biol. 2017 Jul;39(7):1010428317703841. doi: 10.1177/1010428317703841.
7
SOX4 induces tumor invasion by targeting EMT-related pathway in prostate cancer.SOX4通过靶向前列腺癌中的EMT相关途径诱导肿瘤侵袭。
Tumour Biol. 2017 May;39(5):1010428317694539. doi: 10.1177/1010428317694539.
8
Fractionated irradiation-induced EMT-like phenotype conferred radioresistance in esophageal squamous cell carcinoma.分次照射诱导的上皮-间质转化样表型赋予食管鳞状细胞癌放射抗性。
J Radiat Res. 2016 Jul;57(4):370-80. doi: 10.1093/jrr/rrw030. Epub 2016 Apr 28.
9
Increased expression of SOX4 is associated with colorectal cancer progression.SOX4表达增加与结直肠癌进展相关。
Tumour Biol. 2016 Jul;37(7):9131-7. doi: 10.1007/s13277-015-4756-5. Epub 2016 Jan 14.
10
SOX4 contributes to the progression of cervical cancer and the resistance to the chemotherapeutic drug through ABCG2.SOX4 通过ABCG2促进宫颈癌进展及对化疗药物的耐药性。
Cell Death Dis. 2015 Nov 19;6(11):e1990. doi: 10.1038/cddis.2015.290.